Depression common during perimenopause but not regularly assessed by providers

January 22, 2020

CLEVELAND, Ohio (January 21, 2020)--Almost 40% of women experience symptoms of depression during perimenopause, yet it often goes undetected and untreated because many healthcare providers aren't screening for it and aren't prepared with treatment options. A new study analyzed screening practices by women's healthcare providers and their management of depression during perimenopause. Study results are published online in Menopause, the journal of The North American Menopause Society (NAMS).

The high number of women experiencing symptoms of depression has been linked to hormone changes, historical depressive episodes, life events, and a genetic predisposition to depression. As more data emerges to support the presence of risk factors for depression during perimenopause and as the patient population continues to age, healthcare providers need to become better educated in order to recognize and manage depression.

Rates of routine screening and healthcare-provider beliefs and knowledge about symptoms of depression in perimenopause remained unstudied until now. The aim of this new study was to better understand clinical practice patterns of obstetrician-gynecologists regarding their screening practices and management of depression.

The survey was sent to 500 practicing obstetrician-gynecologists who were fellows of the American College of Obstetricians and Gynecologists and members of the Collaborative Ambulatory Research Network. It found that more than a third of respondents (34.1%) did not regularly screen perimenopausal women for depression and that more than half (55%) believed they were not equipped to manage the problem.

Higher-quality education about depression was associated with higher rates of screening. These findings suggest that improved training for obstetrician-gynecologists in the diagnosis, treatment, and management of depression, both in residency and later, could improve rates of screening.

Study results appear in the article "Obstetrician-gynecologists' screening and management of depression during perimenopause."

"Given the prevalence of depressive symptoms in perimenopausal women, the recent publication of guidelines for the diagnosis and management of depression in this population, and the availability of safe and effective therapies, all healthcare providers should be screening their female patients for depression. Improving training for healthcare providers in the evaluation and treatment of depression is important to optimizing patient outcomes," says Dr. Stephanie Faubion, NAMS medical director.
-end-
For more information about menopause and healthy aging, visit http://www.menopause.org.

Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.

The North American Menopause Society (NAMS)

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.